L3VLUP
ProSign in

ITGR · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ITGRJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ITGR
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterITGRJNJ
Q3 20202 holders, $3.3m30 holders, $26.2bn
Q4 20201 holders, $2.3m32 holders, $26.6bn
Q1 20211 holders, $2.5m31 holders, $25.3bn
Q2 20212 holders, $5.7m37 holders, $25.6bn
Q3 20212 holders, $5.2m40 holders, $24.1bn
Q4 20212 holders, $5.4m33 holders, $25.2bn
Q1 20221 holders, $2.3m35 holders, $28.2bn
Q2 20221 holders, $2.0m33 holders, $26.9bn
Q3 20222 holders, $5.0m36 holders, $25.4bn
Q4 20222 holders, $4.6m35 holders, $27.6bn
Q1 20232 holders, $5.4m42 holders, $24.5bn
Q2 20233 holders, $19m38 holders, $25.0bn
Q3 20232 holders, $13m37 holders, $18.9bn
Q4 20233 holders, $28m31 holders, $19.0bn
Q1 20244 holders, $69m32 holders, $19.7bn
Q2 20243 holders, $163m35 holders, $20.4bn
Q3 20243 holders, $305m28 holders, $22.3bn
Q4 20244 holders, $365m37 holders, $20.4bn
Q1 20256 holders, $356m32 holders, $20.5bn
Q2 20257 holders, $376m31 holders, $18.4bn
Q3 20254 holders, $300m32 holders, $23.7bn
Q4 20258 holders, $189m29 holders, $27.8bn
Q1 20264 holders, $262m34 holders, $35.6bn
Q2 20263 holders, $247m33 holders, $39.1bn
ITGR

Integer HLDGS Corp

Holders
3
Reported value
$305m
Buyers
1
Sellers
2

Breadth -1 among 94 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
28
Reported value
$22.3bn
Buyers
13
Sellers
16

Breadth -3 among 94 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2024

Among the 29 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ITGR (1)

Viking Global Investors LP

Only JNJ (26)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Neuberger Berman Group LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Walleye Capital LLC, Wellington Management Group LLP, and 1 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →